Celldex Therapeutics' SWOT analysis: barzolvolimab drives stock potential
Celldex Therapeutics , Inc. (NASDAQ:CLDX), with a market capitalization of $1.72 billion, is a biopharmaceutical company focused on developing innovative therapies for challenging diseases, with its ...
Armed robbery in Revesby20 小时
Investing In Medtech So Patients Can Breathe Easier
The Allan Labor Government is backing local medical technology startup Diag-Nose Medical to develop new treatments for chronic respiratory disorders ...